Respiratory investigation · 2026
Prevalence and functional impact of respiratory sarcopenia in a COPD-enriched smoking cohort.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yoshioka Yuji, Tanabe Naoya, Oshima Yohei, Hamada Ryota, Sato Susumu, Maetani Tomoki, Shiraishi Yusuke, Sato Atsuyasu, Ikeguchi Ryosuke, Hirai Toyohiro
Аннотация
BACKGROUND: Respiratory sarcopenia, defined as a combination of respiratory muscle weakness and decreased respiratory muscle mass, is a novel concept with unclear prevalence and clinical relevance in the chronic obstructive pulmonary disease (COPD) population. This study aimed to evaluate the prevalence of respiratory sarcopenia in a COPD-enriched smoking cohort and its association with clinical features.
METHODS: This prospective observational study included smokers who were categorised into four groups based on respiratory muscle weakness (% maximal inspiratory pressure and/or % maximal expiratory pressure <80%) and low skeletal muscle index (<7.0 kg/m2 for men and <5.7 kg/m2 for women). Pulmonary function, physical function, and the 6-min walking distance (6MWD) were compared between the groups.
RESULTS: A total of 184 smokers (79% with COPD) were classified into the following groups: normal (n = 77, 42%), muscle mass loss only (n = 32, 17%), respiratory muscle weakness only (n = 53, 29%), and probable respiratory sarcopenia (n = 22, 12%). The probable respiratory sarcopenia group demonstrated a significantly lower %FEV1 and elevated RV/TLC. Compared with the other groups, the probable respiratory sarcopenia group exhibited markedly impaired physical performance, with reduced gait speed, 6MWD, and knee extension strength. Multivariable regression analysis revealed that probable respiratory sarcopenia (β = -0.24; p = 0.02) was independently associated with a lower 6MWD after adjusting for age, sex, height, body mass index, smoking pack-year, and FEV1 (adjusted R2 = 0.48).
CONCLUSIONS: Probable respiratory sarcopenia, which was identified in 12% of elderly smokers, was independently associated with exercise capacity and may be a clinical phenotype requiring early detection and intervention to prevent functional decline. Registered at UMIN (UMIN000049755).
METHODS: This prospective observational study included smokers who were categorised into four groups based on respiratory muscle weakness (% maximal inspiratory pressure and/or % maximal expiratory pressure <80%) and low skeletal muscle index (<7.0 kg/m2 for men and <5.7 kg/m2 for women). Pulmonary function, physical function, and the 6-min walking distance (6MWD) were compared between the groups.
RESULTS: A total of 184 smokers (79% with COPD) were classified into the following groups: normal (n = 77, 42%), muscle mass loss only (n = 32, 17%), respiratory muscle weakness only (n = 53, 29%), and probable respiratory sarcopenia (n = 22, 12%). The probable respiratory sarcopenia group demonstrated a significantly lower %FEV1 and elevated RV/TLC. Compared with the other groups, the probable respiratory sarcopenia group exhibited markedly impaired physical performance, with reduced gait speed, 6MWD, and knee extension strength. Multivariable regression analysis revealed that probable respiratory sarcopenia (β = -0.24; p = 0.02) was independently associated with a lower 6MWD after adjusting for age, sex, height, body mass index, smoking pack-year, and FEV1 (adjusted R2 = 0.48).
CONCLUSIONS: Probable respiratory sarcopenia, which was identified in 12% of elderly smokers, was independently associated with exercise capacity and may be a clinical phenotype requiring early detection and intervention to prevent functional decline. Registered at UMIN (UMIN000049755).